Genetic modifications improve the therapeutic efficacy of iPSC-derived CAR-T cells against solid tumors

Focused chemists in lab coats and safety goggles making experiments.

The Shin Kaneko laboratory at CiRA has developed a method to generate CAR-T cells from iPS cells (iCAR-T cells) that possess vastly improved anti-tumor activity in a mouse model of solid tumors.

France vs Morocco livestream options for the 2022 FIFA World Cup semifinals

Previous article

Research finds Mediterranean diet not only boosts health, but also improves fertility

Next article

You may also like


Leave a reply

Your email address will not be published. Required fields are marked *

More in Innovations